OneMedNet Sets September 18 Vote on Reverse Split and Equity Plan Expansion
ONMD sits 19% above its 52-week low of $0.49 on light trading volume (0.3× avg).
Summary
OneMedNet's definitive proxy sets the annual meeting for September 18, 2026, with votes on a reverse stock split (1-for-5 to 1-for-20) and a 1 million share increase to its equity incentive plan.
Key Events · Corporate Governance and Compliance · ONMD
-
Annual Meeting Set for September 18
Stockholders of record on August 11, 2026 will vote on five proposals, including director elections, auditor ratification, equity plan expansion, and a reverse stock split.
-
Reverse Split Range 1-for-5 to 1-for-20
The board seeks authority to implement a reverse split at any ratio between 1-for-5 and 1-for-20 to regain Nasdaq's $1.00 minimum bid compliance by October 12, 2026.
-
Equity Plan Reserve Increase by 1M Shares
Proposal 3 would add 1,000,000 shares to the 2022 Equity Incentive Plan, bringing the aggregate reserve to 3,357,223 shares, with 826,417 currently available.
-
Nasdaq Delisting Risk
The company received a non-compliance notice on April 14, 2026 and has until October 12, 2026 to regain a $1.00 minimum bid price; failure could force a move to OTC markets.
Analysis · ONMD · Industrial Applications And Services
The definitive proxy finalizes the annual meeting date and record date, and adds a new proposal to increase the equity incentive plan by 1 million shares. The reverse split proposal now specifies a 1-for-5 to 1-for-20 range, giving the board discretion to avoid Nasdaq delisting. With cash at $0.4 million and a going-concern warning, these votes are critical to the company's survival and financing flexibility.
At the time of this filing, ONMD was trading at $0.58 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $34.6M. The 52-week trading range was $0.49 to $4.22. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.